Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study.
Barreira-Díaz A, Riveiro-Barciela M, Fernández-Bonilla EM, Bernal V, Castiella A, Casado-Martín M, Delgado C, Londoño MC, Díaz-González Á, Pérez-Medrano I, Conthe A, Sala M, Mateos B, Gómez-Camarero J, Antón-Conejero D, Pozo-Calzada CD, Cuenca F, Villagrasa-Vilella A, Salcedo M. Barreira-Díaz A, et al. Among authors: riveiro barciela m. Ann Hepatol. 2024 May-Jun;29(3):101489. doi: 10.1016/j.aohep.2024.101489. Epub 2024 Feb 23. Ann Hepatol. 2024. PMID: 38403068 Free article.
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury.
Riveiro-Barciela M, Barreira-Díaz A, Salcedo MT, Callejo-Pérez A, Muñoz-Couselo E, Iranzo P, Ortiz-Velez C, Cedrés S, Díaz-Mejía N, Ruiz-Cobo JC, Morales R, Aguilar-Company J, Zamora E, Oliveira M, Sanz-Martínez MT, Viladomiu L, Martínez-Gallo M, Felip E, Buti M. Riveiro-Barciela M, et al. Aliment Pharmacol Ther. 2024 Apr;59(7):865-876. doi: 10.1111/apt.17898. Epub 2024 Feb 7. Aliment Pharmacol Ther. 2024. PMID: 38327102
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.
Kocheise L, Piseddu I, Vonderlin J, Tjwa ET, Buescher G, Meunier L, Goeggelmann P, Fianchi F, Dumortier J, Riveiro Barciela M, Gevers TJG, Terziroli Beretta-Piccoli B, Londoño MC, Frankova S, Roesner T, Joerg V, Schmidt C, Glaser F, Sutter JP, Fründt TW, Lohse AW, Huber S, von Felden J, Sebode M, Schulze K. Kocheise L, et al. Among authors: riveiro barciela m. Front Immunol. 2024 Jan 10;14:1326078. doi: 10.3389/fimmu.2023.1326078. eCollection 2023. Front Immunol. 2024. PMID: 38268921 Free PMC article.
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU.
Riveiro-Barciela M, Carballal S, Díaz-González Á, Mañosa M, Gallego-Plazas J, Cubiella J, Jiménez-Fonseca P, Varela M, Menchén L, Sangro B, Fernández-Montes A, Mesonero F, Rodríguez-Gandía MÁ, Rivera F, Londoño MC. Riveiro-Barciela M, et al. Gastroenterol Hepatol. 2024 Apr;47(4):401-432. doi: 10.1016/j.gastrohep.2023.10.009. Epub 2024 Jan 15. Gastroenterol Hepatol. 2024. PMID: 38228461 English, Spanish.
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU.
Riveiro-Barciela M, Carballal S, Díaz-González Á, Mañosa M, Gallgo-Plazas J, Cubiella J, Jiménez-Fonseca P, Varela M, Menchén L, Sangro B, Fernández-Montes A, Mesonero F, Rodríguez-Gandía MÁ, Rivera F, Londoño MC. Riveiro-Barciela M, et al. Rev Esp Enferm Dig. 2024 Feb;116(2):83-113. doi: 10.17235/reed.2024.10250/2024. Rev Esp Enferm Dig. 2024. PMID: 38226597 Free article.
In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments.
Colomer-Castell S, Gregori J, Garcia-Cehic D, Riveiro-Barciela M, Buti M, Rando-Segura A, Vico-Romero J, Campos C, Ibañez-Lligoña M, Adombi CM, Cortese MF, Tabernero D, Esteban JI, Rodriguez-Frias F, Quer J. Colomer-Castell S, et al. Among authors: riveiro barciela m. Int J Mol Sci. 2023 Dec 6;24(24):17185. doi: 10.3390/ijms242417185. Int J Mol Sci. 2023. PMID: 38139013 Free PMC article.
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study.
Feliu-Prius A, Barreira-Díaz A, Rando A, Vargas-Accarino E, Palom A, Vico-Romero J, Ruiz-Cobo JC, Riveiro-Barciela M, Rodriguez-Frias F, Esteban R, Buti M. Feliu-Prius A, et al. Among authors: riveiro barciela m. Liver Int. 2024 Mar;44(3):706-714. doi: 10.1111/liv.15814. Epub 2023 Dec 18. Liver Int. 2024. PMID: 38111084
Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination.
Llaneras J, Ruiz-Cobo JC, Rando-Segura A, Barreira-Díaz A, Domínguez-Hernández R, Rodríguez-Frías F, Campins M, Colom J, Casado MA, Blanco-Grau A, Bañares J, Monforte A, Falcó-Roget A, Ruíz L, Meza B, Pumarola T, Riveiro-Barciela M, Esteban R, Buti M. Llaneras J, et al. Among authors: riveiro barciela m. JHEP Rep. 2023 Oct 12;6(1):100932. doi: 10.1016/j.jhepr.2023.100932. eCollection 2024 Jan. JHEP Rep. 2023. PMID: 38074506 Free PMC article.
131 results